To the full analysis
Buyback calculator for Emergent BioSolutions
Emergent BioSolutions stock: key metrics
EBSEmergent BioSolutions had an operating margin of 14.8% and a return on invested capital (ROIC) of 7.2% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2006 | 84.2% | 24.9% | 14.9% |
| 2007 | 78.0% | 18.1% | 12.5% |
| 2008 | 80.9% | 16.8% | 11.6% |
| 2009 | 80.3% | 17.1% | 13.3% |
| 2010 | 83.5% | 25.7% | 18.1% |
| 2011 | 84.6% | 11.7% | 8.4% |
| 2012 | 39.9% | 13.0% | 8.3% |
| 2013 | 41.8% | 13.7% | 10.0% |
| 2014 | 48.9% | 22.1% | 9.1% |
| 2015 | 55.7% | 28.9% | 12.8% |
| 2016 | 50.1% | 21.6% | 10.6% |
| 2017 | 50.6% | 22.2% | 14.7% |
| 2018 | 41.0% | 11.5% | 8.0% |
| 2019 | 43.7% | 10.3% | 4.9% |
| 2020 | 54.7% | 27.8% | 19.4% |
| 2021 | 44.7% | 19.2% | 12.4% |
| 2022 | 42.3% | −15.2% | −18.9% |
| 2023 | 34.3% | −69.2% | −72.5% |
| 2024 | 36.0% | −10.4% | −18.3% |
| 2025 | 47.2% | 14.8% | 7.1% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2006 | 16.5% | 21.8% | 9.6% |
| 2007 | 13.4% | 18.5% | 8.4% |
| 2008 | 10.4% | 13.1% | 7.1% |
| 2009 | 12.9% | 13.8% | 9.0% |
| 2010 | 14.0% | 20.7% | 10.3% |
| 2011 | 5.6% | 5.6% | 4.2% |
| 2012 | 5.3% | 6.0% | 4.2% |
| 2013 | 6.4% | 8.1% | 5.0% |
| 2014 | 6.6% | 12.8% | 3.9% |
| 2015 | 9.5% | 17.0% | 6.0% |
| 2016 | 8.7% | 11.1% | 5.3% |
| 2017 | 9.1% | 12.9% | 7.7% |
| 2018 | 6.2% | 5.7% | 2.8% |
| 2019 | 5.0% | 4.7% | 2.3% |
| 2020 | 21.1% | 18.6% | 10.6% |
| 2021 | 13.6% | 13.5% | 7.4% |
| 2022 | −15.2% | −6.6% | −6.7% |
| 2023 | −100.0% | −32.2% | −41.7% |
| 2024 | −39.5% | −7.0% | −13.7% |
| 2025 | 10.1% | 7.2% | 4.0% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 27 Feb 2026)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.